Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.
about
Metabolomic analysis of human cirrhosis, hepatocellular carcinoma, non-alcoholic fatty liver disease and non-alcoholic steatohepatitis diseasesCirculating HMGB1 and RAGE as Clinical Biomarkers in Malignant and Autoimmune DiseasesProtein-Protein Interaction Network could reveal the relationship between the breast and colon cancerDetection of microsatellite instability in gastric cancer and dysplasia tissues.The Serum Concentrations of Chemokine CXCL12 and Its Specific Receptor CXCR4 in Patients with Esophageal Cancer.Ethanol and Cancer Induce Similar Changes on Protein Expression Pattern of Human Fibroblast Cell.Oral squamous cell cancer protein-protein interaction network interpretation in comparison to esophageal adenocarcinoma.Introducing crucial protein panel of gastric adenocarcinoma disease.Protein-protein interaction network analysis of cirrhosis liver disease.Protein-protein interaction network of celiac diseaseTotal Oxidant/Antioxidant Status in Sera of Patients with Esophageal Cancer.Associations between the expression of MTA1 and VEGF-C in esophageal squamous cell carcinoma with lymph angiogenesis and lymph node metastasis.Gastrokine 1 mRNA in human sera is not informative biomarker for gastric cancer.Er:YAG Laser and Cyclosporin A Effect on Cell Cycle Regulation of Human Gingival Fibroblast Cells.Beyond cancer genes: colorectal cancer as robust intrinsic states formed by molecular interactions.Network analysis of common genes related to esophageal, gastric, and colon cancers.Evaluation of involved proteins in colon adenocarcinoma: an interactome analysis.Common and differential genetically pathways between ulcerative colitis and colon adenocarcinoma.
P2860
Q26741550-8E3FC723-E1FF-41CA-88E9-B0426DFFD84DQ26768480-1DA0AC7F-17BE-400A-A87B-B3992EF6A368Q36006139-D605BC6B-042C-45BF-9432-AA457432A6CCQ36493134-F31BECC0-C891-4F56-915D-9EEE26164ED1Q36693716-422D80D5-0A30-4231-90AE-27D9FDEDA839Q37592091-DC39F075-8FEC-4B9C-8019-8E0E436D0E59Q38430692-B90D3CCD-87EE-4579-88B8-218BA7AF24ECQ38435624-FAD0E559-4DE5-49BB-AC70-A2965BA7E533Q38448298-D1652826-A644-450B-BFA5-232A09B1D850Q39147018-045F04B8-4311-4ACF-B906-8E9823816B6CQ41360086-AF36FC1E-200F-4A6A-B703-1CAE61A74EAFQ41621129-B0B84E90-067C-4302-BCB9-196BCF3965DCQ42407047-6460DC29-3F77-4CB5-A83A-0DD39401BF42Q47128764-08029C45-9670-407D-9877-67DFF43E7B99Q47158235-48C83771-54DF-453D-9811-8655D977ED30Q49196010-98289000-DD9A-4F91-8197-6E4C41292334Q53602019-4DC2A559-E64C-4909-AAFE-D81B5AC2B2CBQ54964493-F1A2E1C8-0868-4709-A196-D14BC69C347D
P2860
Introducing biomarker panel in esophageal, gastric, and colon cancers; a proteomic approach.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Introducing biomarker panel in ...... cancers; a proteomic approach.
@en
type
label
Introducing biomarker panel in ...... cancers; a proteomic approach.
@en
prefLabel
Introducing biomarker panel in ...... cancers; a proteomic approach.
@en
P2093
P2860
P1476
Introducing biomarker panel in ...... cancers; a proteomic approach.
@en
P2093
Hadi Hasanzadeh
Mona Zamanian-Azodi
Mostafa Rezaei-Tavirani
Sara Rahmati Rad
Sona Dalilan
P2860
P577
2015-01-01T00:00:00Z